Find the latest SEC Filings data for Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) including 10-K and 10-Q forms at Nasdaq.com.
One other stock from the same industry, Amylyx Pharmaceuticals, Inc. (AMLX), is yet to report results for the quarter ended June 2024. The results are expected to be released on August 8. This company is expected to post quarterly loss of $0.38 per share in its upcoming report, which r...
Verafin’s innovative fraud and AML detection platform, combined with Nasdaq’s leading trade and market surveillance solution, will empower Nasdaq to play an increasingly important role in building stronger economies around the world,” said Adena Friedman, President and Chief Execut...
公司产品Lisaftoclax,是一种新型Bcl-2抑制剂,目前已被美国食品药品监督管理局(FDA)授予五项孤儿药资格认定(ODD),包括用于治疗慢性淋巴细胞白血病(CLL)、急性髓性白血病(AML)和多发性骨髓瘤(MM)。2024年11月,Lisaftoclax的新药上市申请已被国家药品监督管理局药品审评中心接受,并获得优先审评资格。Lisaftoclax新药上...
DWAMLVN $2,060.58 Dorsey Wright Momentum Plus Low Volatility Index Net Total Return +4.94% NQAUMC $1,395.98 NASDAQ Australia Mid Cap Index +16.47% FMREX $11.49 Fidelity Managed Retirement 2030 Fund Retirement +0.02% LIDRW $0.09 AEye, Inc. WT EXP 093027 ...
Nasdaq GEMXand Nasdaq MRX,each of which operates an options market under its own SRO license.AsSROs,each entity has separate rules pertaining to its broker-dealer membersand listed companies,as applicable.Broker-dealers that choose to becomemembers of our exchanges are subject to the rules of ...
is used as the term because, for example, myasthenia gravis opens the door for additional neuromuscular indications. argenx also reported positive results of argx-110 or cusatuzumab in newly diagnosed aml patients in late 2017 and updated results from an expanded patient cohort in november and ...
据CCN报道,近日一些在火币和币安交易的交易员反映,Paxos稳定币对他们的账户进行了提款限制,自12月23日以来一直无法提款,理由是要进行KYC/AML审核。 这些交易员称,Paxos要求等待一周左右,但他们只是在寻找一些不相干的理由阻止兑换PAX,还有些账户直接被关闭了。
SFIX $3.73 0.52% 0.02 PBA $36.32 0.69% 0.25 AMLX $4.02 1.52% 0.06 Access Premium Tools Search Clear Search Advanced Search Search Results Symbols Loading... Private Companies Loading... Recently Viewed Tickers All News Articles Video Podcasts Authors Sections Columns ×...
Aptose Biosciences signs CRADA with NCI to develop tuspetinib for AML, MDS Dec. 3, 2024 at 7:35 a.m. ETon TipRanks.com Aptose Biosciences Boosts Capital with $8M Offering Nov. 25, 2024 at 4:52 p.m. ETon TipRanks.com Why Uxin Shares Are Trading Higher; Here Are 20 Stocks Moving...